Comparez les meilleurs médecins Cancer du foie et les prix en Allemagne. Trouvez votre meilleure correspondance ici.
Nous sélectionnons à la main les meilleurs médecins selon vos besoins et votre budget.
Examiné médicalement par Fahad Mawlood
Éditeur Médical et Scientifique des DonnéesMeilleurs médecins
1
Allemagne
Avis
14000+
De vrais patients
Obtenez gratuitement des plans de traitement personnalisés et choisissez la meilleure option. Sans engagement · Aucun paiement pour nos services
Le Dr Bernd Hertenstein apporte 32 ans d'expertise en oncologie, se spécialisant dans les traitements avancés du cancer du foie à la clinique de Bremen-Mitte.
Choisir une clinique à l'étranger peut être stressant. Chez Bookimed, avec plus de 800 000 patients aidés, nous comprenons vos préoccupations. Nous savons comment trouver des médecins de confiance, les meilleures options qualité-prix, et des solutions pour les cas les plus complexes. Nous sommes là pour vous guider à chaque étape.
Yan Matsiivskiy
Responsable de l'équipe de coordination médicale
4300++ parcours patients accompagnés
3 années chez Bookimed
1022 patients du Germany ont trouvé leur médecin grâce à nous ce mois-ci
Quiz de 2 minutes
Indiquez-nous votre objectif, budget, délai
Appariement humain + IA
Notre algorithme trouve des correspondances, le coordinateur vérifie l'adéquation
Vos options prêtes
Comparez les prix, forfaits, dates. Discutez avec votre coordinateur
Trop de choix ?
Accompagnement de votre traitement
Coordinateurs médicaux personnels formés
| Classement | Médecin | expérience | Bon choix pour | Ce qui les distingue | Clinique et emplacement | Consultation |
|---|---|---|---|---|---|---|
| #1 | Traitements avancés du cancer du foie | Spécialisé dans l'ablation par radiofréquence et la chimioembolisation du cancer du foie. Vaste expérience en matière de transplantation de moelle osseuse et de cellules souches. Contributeur à la recherche en oncologie. | Allemagne | Prix sur demande |
Germany hosts premier liver cancer centers certified by the German Cancer Society and European bodies. Leading university hospitals like Charite Berlin and academic centers such as Medical Center in Solingen specialize in complex resections. They offer advanced therapies including selective internal radiotherapy and immunotherapy.
Bookimed Expert Insight: Patient volume often signals where specialists have the most routine experience with liver resections. For example, Asklepios Altona Clinic manages 85,000+ patients annually. This high frequency typically supports better outcomes. When choosing between academic settings like Solingen or research-heavy hubs like Nordwest, prioritize centers with multidisciplinary tumor boards. These teams better manage complex cases requiring both surgery and interventional radiology.
Patient Consensus: Patients value centers with National Center for Tumor Diseases status for access to new drug trials. While university clinics provide excellent care, some report longer waiting times for initial diagnostic appointments.
Germany leads in non-surgical oncology through advanced interventional radiology and targeted immunotherapies. Key innovations include irreversible electroporation (NanoKnife), Y90 radioembolization, and personalized anticancer vaccines. These procedures target tumors with high precision. They preserve healthy tissue and require minimal recovery time compared to traditional surgery.
Bookimed Expert Insight: Data shows German university centers like Charité Berlin and Nordwest Clinic lead in trial-based innovations. Charité manages over 845,000 patients annually. This volume allows them to offer rare technologies like NanoKnife or specialized vaccines. Prof. Dr. Elke Jaeger at Nordwest has pioneered antitumor vaccines for over 20 years. Patients should target these research-heavy institutions for treatments not yet available in smaller regional hospitals.
Patient Consensus: Patients report that Y90 radioembolization can reduce tumor size significantly within three months. Those undergoing NanoKnife treatments emphasize the rapid recovery. Many return to normal activities in days rather than weeks.
Germany reports a relative 5-year survival rate for liver cancer of approximately 17%. Outcomes improve significantly with early intervention. Liver transplantation leads with success rates between 65% and 76%. Specialized German centers often achieve 70% to 80% success for extensive surgical resections.
Bookimed Expert Insight: German oncology excellence is driven by massive patient volumes and specialized leadership. High-capacity centers like Charite Berlin treat over 845,000 patients annually. Such volume allows surgeons like Prof. Dr. Boris Pfaffenbach to oversee 9,000+ procedures. This depth of experience is why German centers often exceed global survival averages for complex resections.
Patient Consensus: Patients emphasize that accurate staging at high-volume centers is vital for a realistic prognosis. Many note that prioritizing liver health and managed fibrosis pre-treatment significantly impacts their recovery quality.
International patients can access liver cancer treatment in Germany through specialized oncology centers and university hospitals. Clinics accept self-paying individuals or those with international insurance. Treatment includes multidisciplinary tumor boards, advanced SIRT radiation, and precision therapies. Facilities maintain high safety standards under strict national regulations.
Bookimed Expert Insight: While university hospitals like Charite offer immense research power, they often prioritize local patients, causing administrative delays for abroad cases. Smaller, specialized centers like Medical Center in Solingen frequently provide faster intake. Professor Dr. Boris Pfaffenbach at Solingen has performed 9,000 surgeries, offering a high level of surgical expertise with shorter waiting times.
Patient Consensus: Patients note that bringing records translated into German speeds up the process significantly. Many emphasize that choosing private patient status is the most effective way to bypass long waitlists for non-emergency procedures.